26.02.2024

Kit components

Product code

Description

AL3191HVAlphaLISA Human IFNb Detection Kit (100 points)

Components:
AL3191AC
AL3191BC
AL3191S
AL000HV
6760002HV

Anti-IFNb Acceptor Beads
Biotinylated Anti-hIFNb Antibody
AlphaLISA Human IFNb Analyte
AlphaLISA Immunoassay Buffer 10X, 2 mL
Streptavidin Donor Beads

57.0.21

Page 1/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

SECTION 1: Identification of the substance/mixture and of the company/undertaking
ꞏ 1.1 Product identifier
ꞏ Trade name: Anti-IFNb Acceptor Beads
ꞏ Product number: AL3191AC, AL3191AF, AL3191AHV
ꞏ 1.2 Relevant identified uses of the substance or mixture and uses advised against
ꞏ Product category PC21 Laboratory chemicals
ꞏ Application of the substance / the mixture Laboratory chemicals
ꞏ 1.3 Details of the supplier of the safety data sheet
ꞏ Manufacturer/Supplier:Revvity, Inc
549 Albany Street
Boston, MA 02118
ꞏ Further information obtainable from:US Technical Support
800-762-4000
ꞏ 1.4 Emergency telephone number:
If inside USA, call CHEMTREC at 1-800-424-9300
If outside USA, call CHEMTREC at 1-703-527-3887

SECTION 2: Hazards identification
ꞏ 2.1 Classification of the substance or mixture
ꞏ 2.1.1 Classification according to Regulation (EC) No 1272/2008
Skin Irrit. 2
H315 Causes skin irritation.
Eye Irrit. 2
H319 Causes serious eye irritation.
Skin Sens. 1
H317 May cause an allergic skin reaction.
Aquatic Chronic 2 H411 Toxic to aquatic life with long lasting effects.
ꞏ 2.1.3 Additional information: For the wording of the relevant risk phrases refer to section 16.
ꞏ 2.2 Label elements
ꞏ Labelling according to Regulation (EC) No 1272/2008
The product is classified and labelled according to the CLP regulation.
ꞏ Hazard pictograms

GHS07

GHS09

ꞏ Signal word Warningꞏ Hazard-determining components of labelling:
5-chloro-2-methyl-2H-isothiazol-3-one
ꞏ Hazard statements
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H317 May cause an allergic skin reaction.
H411 Toxic to aquatic life with long lasting effects.
ꞏ Precautionary statements
P261
Avoid breathing dust/fume/gas/mist/vapours/spray.
P273
Avoid release to the environment.
P280
Wear protective gloves / eye protection / face protection.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if
present and easy to do. Continue rinsing.
(Contd. on page 2)EU

57.0.21

Page 2/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Anti-IFNb Acceptor Beads(Contd. of page 1)

P333+P313
P501

If skin irritation or rash occurs: Get medical advice/attention.
Dispose of contents/container in accordance with local/regional/national/international
regulations.

ꞏ 2.3 Other hazards
ꞏ Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.

SECTION 3: Composition/information on ingredientsꞏ 3.2 Mixtures
ꞏ Description: Mixture of substances listed below with nonhazardous additions.
ꞏ Dangerous components:
CAS: 26172-55-45-chloro-2-methyl-2H-isothiazol-3-one
EINECS: 247-500-7
Acute Tox. 3, H301; Acute Tox. 2, H310; Acute Tox. 2, H330;
Skin Corr.
1C, H314; Eye Dam. 1, H318;
Aquatic Acute 1, H400 (M=100); Aquatic
Skin Sens. 1A, H317
Chronic 1, H410 (M=100);
Specific concentration limits: Skin Corr. 1C; H314: C ≥ 0.6 %Skin Irrit. 2; H315: 0.06 % ≤ C < 0.6 %Eye Dam. 1; H318: C ≥ 0.6 %Eye Irrit. 2; H319: 0.06 % ≤ C < 0.6 %Skin Sens. 1A; H317: C ≥ 0.0015 %ꞏ Additional information: For the wording of the relevant risk phrases refer to section 16.

<0.1%

SECTION 4: First aid measuresꞏ 4.1 Description of first aid measuresꞏ General information: Immediately remove any clothing soiled by the product.
ꞏ After inhalation:
Supply fresh air and to be sure call for a doctor.
In case of unconsciousness place patient stably in side position for transportation.
ꞏ After eye contact:
Rinse opened eye for several minutes under running water. If symptoms persist, consult a doctor.
ꞏ After swallowing: If symptoms persist consult doctor.
ꞏ 4.2 Most important symptoms and effects, both acute and delayed No further relevant information available.
ꞏ 4.3 Indication of any immediate medical attention and special treatment needed
No further relevant information available.

SECTION 5: Firefighting measuresꞏ 5.1 Extinguishing media
ꞏ Suitable extinguishing agents: Use fire extinguishing methods suitable to surrounding conditions.
ꞏ 5.2 Special hazards arising from the substance or mixture No further relevant information available.
ꞏ 5.3 Advice for firefighters
ꞏ Protective equipment: Wear self-contained respiratory protective device.

SECTION 6: Accidental release measuresꞏ 6.1 Personal precautions, protective equipment and emergency procedures Not required.
(Contd. on page 3)EU

57.0.21

Page 3/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Anti-IFNb Acceptor Beads(Contd. of page 2)

ꞏ 6.2 Environmental precautions:
Do not allow product to reach sewage system or any water course.
Inform respective authorities in case of seepage into water course or sewage system.
Dilute with plenty of water.
Do not allow to enter sewers/ surface or ground water.
ꞏ 6.3 Methods and material for containment and cleaning up:
Absorb with liquid-binding material (sand, diatomite, acid binders, universal binders, sawdust).
Dispose contaminated material as waste according to section 13.
Ensure adequate ventilation.
ꞏ 6.4 Reference to other sections
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.

SECTION 7: Handling and storage
ꞏ 7.1 Precautions for safe handling
Ensure good ventilation/exhaustion at the workplace.
Prevent formation of aerosols.
ꞏ Information about fire - and explosion protection: No special measures required.
ꞏ 7.2 Conditions for safe storage, including any incompatibilities
ꞏ Storage:ꞏ Requirements to be met by storerooms and containers: No special requirements.
ꞏ Information about storage in one common storage facility: Not required.
ꞏ Further information about storage conditions: Keep container tightly sealed.
ꞏ Storage class: 12
ꞏ 7.3 Specific end use(s) No further relevant information available.

SECTION 8: Exposure controls/personal protection
ꞏ 8.1 Control parameters
ꞏ Ingredients with limit values that require monitoring at the workplace:
The product does not contain any relevant quantities of materials with critical values that have to be monitored at
the workplace.
ꞏ 8.2 Exposure controlsꞏ Appropriate engineering controls No further data; see section 7.
ꞏ Individual protection measures, such as personal protective equipment
ꞏ General protective and hygienic measures:
Keep away from foodstuffs, beverages and feed.
Immediately remove all soiled and contaminated clothing
Wash hands before breaks and at the end of work.
Avoid contact with the eyes and skin.
ꞏ Respiratory protection:
In case of brief exposure or low pollution use respiratory filter device. In case of intensive or longer exposure use
self-contained respiratory protective device.
Suitable respiratory protective device recommended.
ꞏ Hand protection
Protective gloves(Contd. on page 4)EU

57.0.21

Page 4/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Anti-IFNb Acceptor Beads(Contd. of page 3)

The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation
ꞏ Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality andvaries from manufacturer to manufacturer. As the product is a preparation of several substances, the resistanceof the glove material can not be calculated in advance and has therefore to be checked prior to the application.
ꞏ Penetration time of glove material
The exact break through time has to be found out by the manufacturer of the protective gloves and has to beobserved.
ꞏ Eye/face protection
Tightly sealed goggles

SECTION 9: Physical and chemical properties
ꞏ 9.1 Information on basic physical and chemical properties
ꞏ General Information
Fluidꞏ Physical state
Colourlessꞏ Colour:Odourlessꞏ Odour:Not determined.
ꞏ Odour threshold:
0 °C
ꞏ Melting point/freezing point:ꞏ Boiling point or initial boiling point and boiling range 100 °C (7732-18-5 Water)
Not applicable.
ꞏ Flammability
ꞏ Lower and upper explosion limit
Not determined.
ꞏ Lower:Not determined.
ꞏ Upper:
Not applicable.
ꞏ Flash point:
Not determined.
ꞏ Decomposition temperature:
Not determined.
ꞏ pH
ꞏ Viscosity:
Not determined.
ꞏ Kinematic viscosity
0.952 mPas
ꞏ Dynamic at 20 °C:
ꞏ Solubility
Fully miscible.
ꞏ water:Not determined.
ꞏ Partition coefficient n-octanol/water (log value)
23 hPa (7732-18-5 Water)ꞏ Vapour pressure at 20 °C:
ꞏ Density and/or relative density
1 g/cm³
ꞏ Density at 20 °C:
Not determined.
ꞏ Relative density
Not determined.
ꞏ Vapour density
ꞏ 9.2 Other information
ꞏ Appearance:
Fluidꞏ Form:ꞏ Important information on protection of health andenvironment, and on safety.
Product is not selfigniting.
ꞏ Ignition temperature:
Product does not present an explosion hazard.
ꞏ Explosive properties:(Contd. on page 5)EU

57.0.21

Page 5/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Anti-IFNb Acceptor Beads(Contd. of page 4)

ꞏ Solvent content:
ꞏ Water:ꞏ Solids content:
ꞏ Molecular weightꞏ Change in condition
ꞏ Evaporation rate

99.0 %
0.0 %18.02 g/mol
Not determined.

ꞏ Information with regard to physical hazard classes
Voidꞏ Explosives
Voidꞏ Flammable gases
Voidꞏ Aerosols
Voidꞏ Oxidising gases
Voidꞏ Gases under pressure
Voidꞏ Flammable liquids
Voidꞏ Flammable solids
Voidꞏ Self-reactive substances and mixtures
Voidꞏ Pyrophoric liquids
Voidꞏ Pyrophoric solids
Voidꞏ Self-heating substances and mixtures
ꞏ Substances and mixtures, which emit flammable gases
Voidin contact with waterVoidꞏ Oxidising liquids
Voidꞏ Oxidising solids
Voidꞏ Organic peroxides
Voidꞏ Corrosive to metals
Voidꞏ Desensitised explosives

SECTION 10: Stability and reactivityꞏ 10.1 Reactivity No further relevant information available.
ꞏ 10.2 Chemical stability
ꞏ Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications.
ꞏ 10.3 Possibility of hazardous reactions No dangerous reactions known.
ꞏ 10.4 Conditions to avoid No further relevant information available.
ꞏ 10.5 Incompatible materials: No further relevant information available.
ꞏ 10.6 Hazardous decomposition products: No dangerous decomposition products known.

SECTION 11: Toxicological information
ꞏ 11.1 Information on hazard classes as defined in Regulation (EC) No 1272/2008
ꞏ Acute toxicity Based on available data, the classification criteria are not met.
ꞏ Skin corrosion/irritation Causes skin irritation.
ꞏ Serious eye damage/irritation Causes serious eye irritation.
ꞏ Respiratory or skin sensitisation May cause an allergic skin reaction.
ꞏ Germ cell mutagenicity Based on available data, the classification criteria are not met.
ꞏ Carcinogenicity Based on available data, the classification criteria are not met.
ꞏ Reproductive toxicity Based on available data, the classification criteria are not met.
ꞏ STOT-single exposure Based on available data, the classification criteria are not met.
ꞏ STOT-repeated exposure Based on available data, the classification criteria are not met.
ꞏ Aspiration hazard Based on available data, the classification criteria are not met.
(Contd. on page 6)EU

57.0.21

Page 6/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Anti-IFNb Acceptor Beads(Contd. of page 5)ꞏ 11.2 Information on other hazards
ꞏ Endocrine disrupting properties
None of the ingredients is listed.

SECTION 12: Ecological information
ꞏ 12.1 Toxicity
ꞏ Aquatic toxicity: No further relevant information available.
ꞏ 12.2 Persistence and degradability No further relevant information available.
ꞏ 12.3 Bioaccumulative potential No further relevant information available.
ꞏ 12.4 Mobility in soil No further relevant information available.
ꞏ 12.5 Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.
ꞏ 12.6 Endocrine disrupting properties
The product does not contain substances with endocrine disrupting properties.
ꞏ 12.7 Other adverse effects
ꞏ Remark: Toxic for fish

SECTION 13: Disposal considerations
ꞏ 13.1 Waste treatment methods
ꞏ Recommendation
Must not be disposed together with household garbage. Do not allow product to reach sewage system.
Hand over to hazardous waste disposers.
Must be specially treated adhering to official regulations.
ꞏ Uncleaned packaging:ꞏ Recommendation: Disposal must be made according to official regulations.
ꞏ Recommended cleansing agents: Water, if necessary together with cleansing agents.

SECTION 14: Transport information
ꞏ 14.1 UN number or ID number
ꞏ ADR, IMDG, IATAꞏ 14.2 UN proper shipping name
ꞏ ADR
ꞏ IMDG
ꞏ IATA

UN30823082 ENVIRONMENTALLY HAZARDOUS SUBSTANCE,LIQUID, N.O.S. (CYANOGEN BROMIDE)
ENVIRONMENTALLY HAZARDOUS SUBSTANCE,LIQUID, N.O.S. (CYANOGEN BROMIDE), MARINEPOLLUTANTENVIRONMENTALLY HAZARDOUS SUBSTANCE,LIQUID, N.O.S. (CYANOGEN BROMIDE)(Contd. on page 7)EU

57.0.21

Page 7/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Anti-IFNb Acceptor Beads(Contd. of page 6)

ꞏ 14.3 Transport hazard class(es)ꞏ ADR, IMDG, IATA

ꞏ Class
ꞏ Label9 Miscellaneous dangerous substances and articles.
9ꞏ 14.4 Packing group
ꞏ ADR, IMDG, IATAIII

ꞏ 14.5 Environmental hazards:
ꞏ Marine pollutant:ꞏ Special marking (ADR):ꞏ Special marking (IATA):

Symbol (fish and tree)
Symbol (fish and tree)
Symbol (fish and tree)

ꞏ 14.6 Special precautions for user
ꞏ Hazard identification number (Kemler code):ꞏ EMS Number:ꞏ Segregation groupsꞏ Stowage Category

Warning: Miscellaneous dangerous substances and articles.
90
F-A,S-F(SGG6) CyanidesAꞏ 14.7 Maritime transport in bulk according to IMO
Not applicable.
instruments
ꞏ Transport/Additional information:
ꞏ ADR
ꞏ Limited quantities (LQ)ꞏ Excepted quantities (EQ)ꞏ Transport categoryꞏ Tunnel restriction codeꞏ IMDGꞏ Limited quantities (LQ)ꞏ Excepted quantities (EQ)ꞏ UN "Model Regulation":

5L
Code: E1
Maximum net quantity per inner packaging: 30 ml
Maximum net quantity per outer packaging: 1000 ml
3(-)
5L
Code: E1
Maximum net quantity per inner packaging: 30 ml
Maximum net quantity per outer packaging: 1000 ml
UN 3082 ENVIRONMENTALLY HAZARDOUS
SUBSTANCE, LIQUID, N.O.S. (CYANOGEN BROMIDE), 9,III

SECTION 15: Regulatory information
ꞏ 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixtureꞏ Directive 2012/18/EU
ꞏ Named dangerous substances - ANNEX I None of the ingredients is listed.
ꞏ Seveso category E2 Hazardous to the Aquatic Environment
ꞏ Qualifying quantity (tonnes) for the application of lower-tier requirements 200 t
ꞏ Qualifying quantity (tonnes) for the application of upper-tier requirements 500 t(Contd. on page 8)EU

57.0.21

Page 8/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Anti-IFNb Acceptor Beads(Contd. of page 7)

ꞏ REGULATION (EC) No 1907/2006 ANNEX XVII Conditions of restriction: 3
ꞏ DIRECTIVE 2011/65/EU on the restriction of the use of certain hazardous substances in electrical andelectronic equipment – Annex II
None of the ingredients is listed.
ꞏ REGULATION (EU) 2019/1148
ꞏ Annex I - RESTRICTED EXPLOSIVES PRECURSORS (Upper limit value for the purpose of licensing under
Article 5(3))
None of the ingredients is listed.
ꞏ Annex II - REPORTABLE EXPLOSIVES PRECURSORSNone of the ingredients is listed.
ꞏ Regulation (EC) No 273/2004 on drug precursors
None of the ingredients is listed.
ꞏ Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third
countries in drug precursors
None of the ingredients is listed.
ꞏ 15.2 Chemical safety assessment: A Chemical Safety Assessment has not been carried out.

SECTION 16: Other information
The information provided in this safety data sheet is based on our current knowledge,
and is believed to be correct at the date of publication. However, no representation is madeconcerning its accuracy and completeness. It is intended as guidance only, and is not to be regarded as awarranty or specification of quality. All materials may present unknown hazards and should be used withcaution. Although certain hazards are described, we cannot guarantee that these are the only hazards that exist.
Revvity, Inc. cannot be held liable for any damage resulting from handling or contact with the product.
ꞏ Abbreviations and acronyms:
ADR: Accord relatif au transport international des marchandises dangereuses par route (European Agreement Concerning the International
Carriage of Dangerous Goods by Road)
IMDG: International Maritime Code for Dangerous Goods
IATA: International Air Transport Association
GHS: Globally Harmonised System of Classification and Labelling of Chemicals
EINECS: European Inventory of Existing Commercial Chemical Substances
ELINCS: European List of Notified Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
PBT: Persistent, Bioaccumulative and Toxic
vPvB: very Persistent and very Bioaccumulative
Acute Tox. 3: Acute toxicity – Category 3
Acute Tox. 2: Acute toxicity – Category 2
Skin Corr. 1C: Skin corrosion/irritation – Category 1C
Skin Irrit. 2: Skin corrosion/irritation – Category 2
Eye Dam. 1: Serious eye damage/eye irritation – Category 1
Eye Irrit. 2: Serious eye damage/eye irritation – Category 2
Skin Sens. 1: Skin sensitisation – Category 1
Skin Sens. 1A: Skin sensitisation – Category 1AAquatic Acute 1: Hazardous to the aquatic environment - acute aquatic hazard – Category 1
Aquatic Chronic 1: Hazardous to the aquatic environment - long-term aquatic hazard – Category 1
Aquatic Chronic 2: Hazardous to the aquatic environment - long-term aquatic hazard – Category 2EU57.0.21

Page 1/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

SECTION 1: Identification of the substance/mixture and of the company/undertaking
ꞏ 1.1 Product identifier
ꞏ Trade name: Biotinylated Anti-hIFNb Antibody
ꞏ Product number: AL3191BC, AL3191BF, AL3191BHV
ꞏ 1.2 Relevant identified uses of the substance or mixture and uses advised against
ꞏ Product category PC21 Laboratory chemicals
ꞏ Application of the substance / the mixture Laboratory chemicals
ꞏ 1.3 Details of the supplier of the safety data sheet
ꞏ Manufacturer/Supplier:Revvity, Inc
549 Albany Street
Boston, MA 02118
ꞏ Further information obtainable from:US Technical Support
800-762-4000
ꞏ 1.4 Emergency telephone number:
If inside USA, call CHEMTREC at 1-800-424-9300
If outside USA, call CHEMTREC at 1-703-527-3887

SECTION 2: Hazards identification
ꞏ 2.1 Classification of the substance or mixture
ꞏ 2.1.1 Classification according to Regulation (EC) No 1272/2008
The product is not classified, according to the CLP regulation.
ꞏ 2.2 Label elements
ꞏ Labelling according to Regulation (EC) No 1272/2008 Void
ꞏ Hazard pictograms Void
ꞏ Signal word Void
ꞏ Hazard statements Void
ꞏ 2.3 Other hazards
ꞏ Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.

SECTION 3: Composition/information on ingredientsꞏ 3.2 Mixtures
ꞏ Description: Mixture of substances listed below with nonhazardous additions.
ꞏ Dangerous components: Void
ꞏ Additional information: For the wording of the relevant risk phrases refer to section 16.

SECTION 4: First aid measuresꞏ 4.1 Description of first aid measuresꞏ General information: No special measures required.
ꞏ After inhalation: Supply fresh air; consult doctor in case of complaints.
ꞏ After skin contact: If skin irritation continues, consult a doctor.
ꞏ After eye contact: Rinse opened eye for several minutes under running water.
ꞏ After swallowing: If symptoms persist consult doctor.
ꞏ 4.2 Most important symptoms and effects, both acute and delayed No further relevant information available.
(Contd. on page 2)EU

57.0.21

Page 2/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Biotinylated Anti-hIFNb Antibody(Contd. of page 1)

ꞏ 4.3 Indication of any immediate medical attention and special treatment needed
No further relevant information available.

SECTION 5: Firefighting measuresꞏ 5.1 Extinguishing media
ꞏ Suitable extinguishing agents: Use fire extinguishing methods suitable to surrounding conditions.
ꞏ 5.2 Special hazards arising from the substance or mixture No further relevant information available.
ꞏ 5.3 Advice for firefighters
ꞏ Protective equipment: Wear self-contained respiratory protective device.

SECTION 6: Accidental release measuresꞏ 6.1 Personal precautions, protective equipment and emergency procedures Not required.
ꞏ 6.2 Environmental precautions:
Dilute with plenty of water.
Do not allow to enter sewers/ surface or ground water.
ꞏ 6.3 Methods and material for containment and cleaning up:
Absorb with liquid-binding material (sand, diatomite, acid binders, universal binders, sawdust).
ꞏ 6.4 Reference to other sections
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.

SECTION 7: Handling and storage
ꞏ 7.1 Precautions for safe handling No special measures required.
ꞏ Information about fire - and explosion protection: No special measures required.
ꞏ 7.2 Conditions for safe storage, including any incompatibilities
ꞏ Storage:ꞏ Requirements to be met by storerooms and containers: No special requirements.
ꞏ Information about storage in one common storage facility: Not required.
ꞏ Further information about storage conditions: None.
ꞏ Storage class: 12
ꞏ 7.3 Specific end use(s) No further relevant information available.

SECTION 8: Exposure controls/personal protection
ꞏ 8.1 Control parameters
ꞏ Ingredients with limit values that require monitoring at the workplace:
The product does not contain any relevant quantities of materials with critical values that have to be monitored at
the workplace.
ꞏ 8.2 Exposure controlsꞏ Appropriate engineering controls No further data; see section 7.
ꞏ Individual protection measures, such as personal protective equipment
ꞏ General protective and hygienic measures:
The usual precautionary measures are to be adhered to when handling chemicals.
ꞏ Respiratory protection: Not required.
(Contd. on page 3)EU

57.0.21

Page 3/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Biotinylated Anti-hIFNb Antibody(Contd. of page 2)

ꞏ Hand protection
The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation
ꞏ Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality andvaries from manufacturer to manufacturer. As the product is a preparation of several substances, the resistanceof the glove material can not be calculated in advance and has therefore to be checked prior to the application.
ꞏ Penetration time of glove material
The exact break through time has to be found out by the manufacturer of the protective gloves and has to beobserved.
ꞏ Eye/face protection Goggles recommended during refilling

SECTION 9: Physical and chemical properties
ꞏ 9.1 Information on basic physical and chemical properties
ꞏ General Information
Fluidꞏ Physical state
According to product specification
ꞏ Colour:Characteristic
ꞏ Odour:Not determined.
ꞏ Odour threshold:
Undetermined.
ꞏ Melting point/freezing point:ꞏ Boiling point or initial boiling point and boiling range 100 °C (7732-18-5 Water)
Not applicable.
ꞏ Flammability
ꞏ Lower and upper explosion limit
Not determined.
ꞏ Lower:Not determined.
ꞏ Upper:
Not applicable.
ꞏ Flash point:
Not determined.
ꞏ Decomposition temperature:
Not determined.
ꞏ pH
ꞏ Viscosity:
Not determined.
ꞏ Kinematic viscosity
Not determined.
ꞏ Dynamic:
ꞏ Solubility
Fully miscible.
ꞏ water:Not determined.
ꞏ Partition coefficient n-octanol/water (log value)
23 hPa (7732-18-5 Water)ꞏ Vapour pressure at 20 °C:
ꞏ Density and/or relative density
Not determined.
ꞏ Density:
Not determined.
ꞏ Relative density
Not determined.
ꞏ Vapour density
ꞏ 9.2 Other information
ꞏ Appearance:
Fluidꞏ Form:ꞏ Important information on protection of health andenvironment, and on safety.
Product is not selfigniting.
ꞏ Ignition temperature:
Product does not present an explosion hazard.
ꞏ Explosive properties:
ꞏ Solvent content:
93.7 %
ꞏ Water:
3.2 %ꞏ Solids content:(Contd. on page 4)EU

57.0.21

Page 4/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Biotinylated Anti-hIFNb Antibody(Contd. of page 3)

ꞏ Change in condition
ꞏ Evaporation rate

Not determined.

ꞏ Information with regard to physical hazard classes
Voidꞏ Explosives
Voidꞏ Flammable gases
Voidꞏ Aerosols
Voidꞏ Oxidising gases
Voidꞏ Gases under pressure
Voidꞏ Flammable liquids
Voidꞏ Flammable solids
Voidꞏ Self-reactive substances and mixtures
Voidꞏ Pyrophoric liquids
Voidꞏ Pyrophoric solids
Voidꞏ Self-heating substances and mixtures
ꞏ Substances and mixtures, which emit flammable gases
Voidin contact with waterVoidꞏ Oxidising liquids
Voidꞏ Oxidising solids
Voidꞏ Organic peroxides
Voidꞏ Corrosive to metals
Voidꞏ Desensitised explosives

SECTION 10: Stability and reactivityꞏ 10.1 Reactivity No further relevant information available.
ꞏ 10.2 Chemical stability
ꞏ Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications.
ꞏ 10.3 Possibility of hazardous reactions No dangerous reactions known.
ꞏ 10.4 Conditions to avoid No further relevant information available.
ꞏ 10.5 Incompatible materials: No further relevant information available.
ꞏ 10.6 Hazardous decomposition products: No dangerous decomposition products known.

SECTION 11: Toxicological information
ꞏ 11.1 Information on hazard classes as defined in Regulation (EC) No 1272/2008
ꞏ Acute toxicity Based on available data, the classification criteria are not met.
ꞏ Skin corrosion/irritation Based on available data, the classification criteria are not met.
ꞏ Serious eye damage/irritation Based on available data, the classification criteria are not met.
ꞏ Respiratory or skin sensitisation Based on available data, the classification criteria are not met.
ꞏ Germ cell mutagenicity Based on available data, the classification criteria are not met.
ꞏ Carcinogenicity Based on available data, the classification criteria are not met.
ꞏ Reproductive toxicity Based on available data, the classification criteria are not met.
ꞏ STOT-single exposure Based on available data, the classification criteria are not met.
ꞏ STOT-repeated exposure Based on available data, the classification criteria are not met.
ꞏ Aspiration hazard Based on available data, the classification criteria are not met.
ꞏ 11.2 Information on other hazards
ꞏ Endocrine disrupting properties
None of the ingredients is listed.
EU(Contd. on page 5)

57.0.21

Page 5/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Biotinylated Anti-hIFNb Antibody(Contd. of page 4)

SECTION 12: Ecological information
ꞏ 12.1 Toxicity
ꞏ Aquatic toxicity: No further relevant information available.
ꞏ 12.2 Persistence and degradability No further relevant information available.
ꞏ 12.3 Bioaccumulative potential No further relevant information available.
ꞏ 12.4 Mobility in soil No further relevant information available.
ꞏ 12.5 Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.
ꞏ 12.6 Endocrine disrupting properties
The product does not contain substances with endocrine disrupting properties.
ꞏ 12.7 Other adverse effects No further relevant information available.

SECTION 13: Disposal considerations
ꞏ 13.1 Waste treatment methods
ꞏ Recommendation
Smaller quantities can be disposed of with household waste.
Must be specially treated adhering to official regulations.
ꞏ Uncleaned packaging:ꞏ Recommendation: Disposal must be made according to official regulations.
ꞏ Recommended cleansing agents: Water, if necessary together with cleansing agents.

SECTION 14: Transport information
ꞏ 14.1 UN number or ID number
ꞏ ADR, IMDG, IATA

Void

ꞏ 14.2 UN proper shipping nameꞏ ADR, IMDG, IATA

Void

ꞏ 14.3 Transport hazard class(es)ꞏ ADR, ADN, IMDG, IATA
ꞏ ClassVoidꞏ 14.4 Packing group
ꞏ ADR, IMDG, IATA

Void

ꞏ 14.5 Environmental hazards:

Not applicable.

ꞏ 14.6 Special precautions for user

Not applicable.

ꞏ 14.7 Maritime transport in bulk according to IMO
Not applicable.
instruments
ꞏ UN "Model Regulation":

Void
EU

(Contd. on page 6)

57.0.21

Page 6/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: Biotinylated Anti-hIFNb Antibody(Contd. of page 5)

SECTION 15: Regulatory information
ꞏ 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixtureꞏ Directive 2012/18/EU
ꞏ Named dangerous substances - ANNEX I None of the ingredients is listed.
ꞏ DIRECTIVE 2011/65/EU on the restriction of the use of certain hazardous substances in electrical andelectronic equipment – Annex II
None of the ingredients is listed.
ꞏ REGULATION (EU) 2019/1148
ꞏ Annex I - RESTRICTED EXPLOSIVES PRECURSORS (Upper limit value for the purpose of licensing under
Article 5(3))
None of the ingredients is listed.
ꞏ Annex II - REPORTABLE EXPLOSIVES PRECURSORSNone of the ingredients is listed.
ꞏ Regulation (EC) No 273/2004 on drug precursors
None of the ingredients is listed.
ꞏ Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third
countries in drug precursors
None of the ingredients is listed.
ꞏ 15.2 Chemical safety assessment: A Chemical Safety Assessment has not been carried out.

SECTION 16: Other information
The information provided in this safety data sheet is based on our current knowledge,
and is believed to be correct at the date of publication. However, no representation is madeconcerning its accuracy and completeness. It is intended as guidance only, and is not to be regarded as awarranty or specification of quality. All materials may present unknown hazards and should be used withcaution. Although certain hazards are described, we cannot guarantee that these are the only hazards that exist.
Revvity, Inc. cannot be held liable for any damage resulting from handling or contact with the product.
ꞏ Abbreviations and acronyms:
ADR: Accord relatif au transport international des marchandises dangereuses par route (European Agreement Concerning the International
Carriage of Dangerous Goods by Road)
IMDG: International Maritime Code for Dangerous Goods
IATA: International Air Transport Association
GHS: Globally Harmonised System of Classification and Labelling of Chemicals
EINECS: European Inventory of Existing Commercial Chemical Substances
ELINCS: European List of Notified Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
PBT: Persistent, Bioaccumulative and Toxic
vPvB: very Persistent and very BioaccumulativeEU57.0.21

Page 1/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

SECTION 1: Identification of the substance/mixture and of the company/undertaking
ꞏ 1.1 Product identifier
ꞏ Trade name: AlphaLISA Human IFNb Analyteꞏ Product number: AL3191S
ꞏ 1.2 Relevant identified uses of the substance or mixture and uses advised against
ꞏ Product category PC21 Laboratory chemicals
ꞏ Application of the substance / the mixture Laboratory chemicals
ꞏ 1.3 Details of the supplier of the safety data sheet
ꞏ Manufacturer/Supplier:Revvity, Inc
549 Albany Street
Boston, MA 02118
ꞏ Further information obtainable from:US Technical Support
800-762-4000
ꞏ 1.4 Emergency telephone number:
If inside USA, call CHEMTREC at 1-800-424-9300
If outside USA, call CHEMTREC at 1-703-527-3887

SECTION 2: Hazards identification
ꞏ 2.1 Classification of the substance or mixture
ꞏ 2.1.1 Classification according to Regulation (EC) No 1272/2008
Skin Irrit. 2
H315 Causes skin irritation.
Eye Irrit. 2
H319 Causes serious eye irritation.
Skin Sens. 1
H317 May cause an allergic skin reaction.
Aquatic Chronic 2 H411 Toxic to aquatic life with long lasting effects.
ꞏ 2.1.3 Additional information: For the wording of the relevant risk phrases refer to section 16.
ꞏ 2.2 Label elements
ꞏ Labelling according to Regulation (EC) No 1272/2008
The product is classified and labelled according to the CLP regulation.
ꞏ Hazard pictograms

GHS07

GHS09

ꞏ Signal word Warningꞏ Hazard-determining components of labelling:
5-chloro-2-methyl-2H-isothiazol-3-one
ꞏ Hazard statements
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H317 May cause an allergic skin reaction.
H411 Toxic to aquatic life with long lasting effects.
ꞏ Precautionary statements
P261
Avoid breathing dust/fume/gas/mist/vapours/spray.
P273
Avoid release to the environment.
P280
Wear protective gloves / eye protection / face protection.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if
present and easy to do. Continue rinsing.
(Contd. on page 2)EU

57.0.21

Page 2/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: AlphaLISA Human IFNb Analyte(Contd. of page 1)

P333+P313
P501

If skin irritation or rash occurs: Get medical advice/attention.
Dispose of contents/container in accordance with local/regional/national/international
regulations.

ꞏ 2.3 Other hazards
ꞏ Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.

SECTION 3: Composition/information on ingredientsꞏ 3.2 Mixtures
ꞏ Description: Mixture of substances listed below with nonhazardous additions.
ꞏ Dangerous components:
CAS: 26172-55-45-chloro-2-methyl-2H-isothiazol-3-one
EINECS: 247-500-7
Acute Tox. 3, H301; Acute Tox. 2, H310; Acute Tox. 2, H330;
Skin Corr.
1C, H314; Eye Dam. 1, H318;
Aquatic Acute 1, H400 (M=100); Aquatic
Skin Sens. 1A, H317
Chronic 1, H410 (M=100);
Specific concentration limits: Skin Corr. 1C; H314: C ≥ 0.6 %Skin Irrit. 2; H315: 0.06 % ≤ C < 0.6 %Eye Dam. 1; H318: C ≥ 0.6 %Eye Irrit. 2; H319: 0.06 % ≤ C < 0.6 %Skin Sens. 1A; H317: C ≥ 0.0015 %ꞏ Additional information: For the wording of the relevant risk phrases refer to section 16.

<0.1%

SECTION 4: First aid measuresꞏ 4.1 Description of first aid measuresꞏ General information: Immediately remove any clothing soiled by the product.
ꞏ After inhalation:
Supply fresh air and to be sure call for a doctor.
In case of unconsciousness place patient stably in side position for transportation.
ꞏ After eye contact:
Rinse opened eye for several minutes under running water. If symptoms persist, consult a doctor.
ꞏ After swallowing: If symptoms persist consult doctor.
ꞏ 4.2 Most important symptoms and effects, both acute and delayed No further relevant information available.
ꞏ 4.3 Indication of any immediate medical attention and special treatment needed
No further relevant information available.

SECTION 5: Firefighting measuresꞏ 5.1 Extinguishing media
ꞏ Suitable extinguishing agents: Use fire extinguishing methods suitable to surrounding conditions.
ꞏ 5.2 Special hazards arising from the substance or mixture No further relevant information available.
ꞏ 5.3 Advice for firefighters
ꞏ Protective equipment: Wear self-contained respiratory protective device.

SECTION 6: Accidental release measuresꞏ 6.1 Personal precautions, protective equipment and emergency procedures Not required.
(Contd. on page 3)EU

57.0.21

Page 3/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: AlphaLISA Human IFNb Analyte(Contd. of page 2)

ꞏ 6.2 Environmental precautions:
Do not allow product to reach sewage system or any water course.
Inform respective authorities in case of seepage into water course or sewage system.
Dilute with plenty of water.
Do not allow to enter sewers/ surface or ground water.
ꞏ 6.3 Methods and material for containment and cleaning up:
Absorb with liquid-binding material (sand, diatomite, acid binders, universal binders, sawdust).
Dispose contaminated material as waste according to section 13.
Ensure adequate ventilation.
ꞏ 6.4 Reference to other sections
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.

SECTION 7: Handling and storage
ꞏ 7.1 Precautions for safe handling
Ensure good ventilation/exhaustion at the workplace.
Prevent formation of aerosols.
ꞏ Information about fire - and explosion protection: No special measures required.
ꞏ 7.2 Conditions for safe storage, including any incompatibilities
ꞏ Storage:ꞏ Requirements to be met by storerooms and containers: No special requirements.
ꞏ Information about storage in one common storage facility: Not required.
ꞏ Further information about storage conditions: Keep container tightly sealed.
ꞏ Storage class: 12
ꞏ 7.3 Specific end use(s) No further relevant information available.

SECTION 8: Exposure controls/personal protection
ꞏ 8.1 Control parameters
ꞏ Ingredients with limit values that require monitoring at the workplace:
The product does not contain any relevant quantities of materials with critical values that have to be monitored at
the workplace.
ꞏ 8.2 Exposure controlsꞏ Appropriate engineering controls No further data; see section 7.
ꞏ Individual protection measures, such as personal protective equipment
ꞏ General protective and hygienic measures:
Keep away from foodstuffs, beverages and feed.
Immediately remove all soiled and contaminated clothing
Wash hands before breaks and at the end of work.
Avoid contact with the eyes and skin.
ꞏ Respiratory protection:
In case of brief exposure or low pollution use respiratory filter device. In case of intensive or longer exposure use
self-contained respiratory protective device.
Suitable respiratory protective device recommended.
ꞏ Hand protection
Protective gloves(Contd. on page 4)EU

57.0.21

Page 4/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: AlphaLISA Human IFNb Analyte(Contd. of page 3)

The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation
ꞏ Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality andvaries from manufacturer to manufacturer. As the product is a preparation of several substances, the resistanceof the glove material can not be calculated in advance and has therefore to be checked prior to the application.
ꞏ Penetration time of glove material
The exact break through time has to be found out by the manufacturer of the protective gloves and has to beobserved.
ꞏ Eye/face protection
Tightly sealed goggles

SECTION 9: Physical and chemical properties
ꞏ 9.1 Information on basic physical and chemical properties
ꞏ General Information
Fluidꞏ Physical state
According to product specification
ꞏ Colour:Characteristic
ꞏ Odour:Not determined.
ꞏ Odour threshold:
Undetermined.
ꞏ Melting point/freezing point:ꞏ Boiling point or initial boiling point and boiling range 100 °C (7732-18-5 Water)
Not applicable.
ꞏ Flammability
ꞏ Lower and upper explosion limit
Not determined.
ꞏ Lower:Not determined.
ꞏ Upper:
Not applicable.
ꞏ Flash point:
Not determined.
ꞏ Decomposition temperature:
Not determined.
ꞏ pH
ꞏ Viscosity:
Not determined.
ꞏ Kinematic viscosity
Not determined.
ꞏ Dynamic:
ꞏ Solubility
Fully miscible.
ꞏ water:Not determined.
ꞏ Partition coefficient n-octanol/water (log value)
23 hPa (7732-18-5 Water)ꞏ Vapour pressure at 20 °C:
ꞏ Density and/or relative density
Not determined.
ꞏ Density:
Not determined.
ꞏ Relative density
Not determined.
ꞏ Vapour density
ꞏ 9.2 Other information
ꞏ Appearance:
Fluidꞏ Form:ꞏ Important information on protection of health andenvironment, and on safety.
Product is not selfigniting.
ꞏ Ignition temperature:
Product does not present an explosion hazard.
ꞏ Explosive properties:(Contd. on page 5)EU

57.0.21

Page 5/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: AlphaLISA Human IFNb Analyte(Contd. of page 4)

ꞏ Solvent content:
ꞏ Water:ꞏ Solids content:
ꞏ Change in condition
ꞏ Evaporation rate

49.0 %
5.5 %Not determined.

ꞏ Information with regard to physical hazard classes
Voidꞏ Explosives
Voidꞏ Flammable gases
Voidꞏ Aerosols
Voidꞏ Oxidising gases
Voidꞏ Gases under pressure
Voidꞏ Flammable liquids
Voidꞏ Flammable solids
Voidꞏ Self-reactive substances and mixtures
Voidꞏ Pyrophoric liquids
Voidꞏ Pyrophoric solids
Voidꞏ Self-heating substances and mixtures
ꞏ Substances and mixtures, which emit flammable gases
Voidin contact with waterVoidꞏ Oxidising liquids
Voidꞏ Oxidising solids
Voidꞏ Organic peroxides
Voidꞏ Corrosive to metals
Voidꞏ Desensitised explosives

SECTION 10: Stability and reactivityꞏ 10.1 Reactivity No further relevant information available.
ꞏ 10.2 Chemical stability
ꞏ Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications.
ꞏ 10.3 Possibility of hazardous reactions No dangerous reactions known.
ꞏ 10.4 Conditions to avoid No further relevant information available.
ꞏ 10.5 Incompatible materials: No further relevant information available.
ꞏ 10.6 Hazardous decomposition products: No dangerous decomposition products known.

SECTION 11: Toxicological information
ꞏ 11.1 Information on hazard classes as defined in Regulation (EC) No 1272/2008
ꞏ Acute toxicity Based on available data, the classification criteria are not met.
ꞏ Skin corrosion/irritation Causes skin irritation.
ꞏ Serious eye damage/irritation Causes serious eye irritation.
ꞏ Respiratory or skin sensitisation May cause an allergic skin reaction.
ꞏ Germ cell mutagenicity Based on available data, the classification criteria are not met.
ꞏ Carcinogenicity Based on available data, the classification criteria are not met.
ꞏ Reproductive toxicity Based on available data, the classification criteria are not met.
ꞏ STOT-single exposure Based on available data, the classification criteria are not met.
ꞏ STOT-repeated exposure Based on available data, the classification criteria are not met.
ꞏ Aspiration hazard Based on available data, the classification criteria are not met.
(Contd. on page 6)EU

57.0.21

Page 6/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: AlphaLISA Human IFNb Analyte(Contd. of page 5)ꞏ 11.2 Information on other hazards
ꞏ Endocrine disrupting properties
None of the ingredients is listed.

SECTION 12: Ecological information
ꞏ 12.1 Toxicity
ꞏ Aquatic toxicity: No further relevant information available.
ꞏ 12.2 Persistence and degradability No further relevant information available.
ꞏ 12.3 Bioaccumulative potential No further relevant information available.
ꞏ 12.4 Mobility in soil No further relevant information available.
ꞏ 12.5 Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.
ꞏ 12.6 Endocrine disrupting properties
The product does not contain substances with endocrine disrupting properties.
ꞏ 12.7 Other adverse effects
ꞏ Remark: Toxic for fish

SECTION 13: Disposal considerations
ꞏ 13.1 Waste treatment methods
ꞏ Recommendation
Must not be disposed together with household garbage. Do not allow product to reach sewage system.
Hand over to hazardous waste disposers.
Must be specially treated adhering to official regulations.
ꞏ Uncleaned packaging:ꞏ Recommendation: Disposal must be made according to official regulations.
ꞏ Recommended cleansing agents: Water, if necessary together with cleansing agents.

SECTION 14: Transport information
ꞏ 14.1 UN number or ID number
ꞏ ADR, IMDG, IATAꞏ 14.2 UN proper shipping name
ꞏ ADR
ꞏ IMDG
ꞏ IATA

UN30823082 ENVIRONMENTALLY HAZARDOUS SUBSTANCE,LIQUID, N.O.S. (CYANOGEN BROMIDE)
ENVIRONMENTALLY HAZARDOUS SUBSTANCE,LIQUID, N.O.S. (CYANOGEN BROMIDE), MARINEPOLLUTANTENVIRONMENTALLY HAZARDOUS SUBSTANCE,LIQUID, N.O.S. (CYANOGEN BROMIDE)(Contd. on page 7)EU

57.0.21

Page 7/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: AlphaLISA Human IFNb Analyte(Contd. of page 6)

ꞏ 14.3 Transport hazard class(es)ꞏ ADR, IMDG, IATA

ꞏ Class
ꞏ Label9 Miscellaneous dangerous substances and articles.
9ꞏ 14.4 Packing group
ꞏ ADR, IMDG, IATAIII

ꞏ 14.5 Environmental hazards:
ꞏ Marine pollutant:ꞏ Special marking (ADR):ꞏ Special marking (IATA):

Symbol (fish and tree)
Symbol (fish and tree)
Symbol (fish and tree)

ꞏ 14.6 Special precautions for user
ꞏ Hazard identification number (Kemler code):ꞏ EMS Number:ꞏ Segregation groupsꞏ Stowage Category

Warning: Miscellaneous dangerous substances and articles.
90
F-A,S-F(SGG6) CyanidesAꞏ 14.7 Maritime transport in bulk according to IMO
Not applicable.
instruments
ꞏ Transport/Additional information:
ꞏ ADR
ꞏ Limited quantities (LQ)ꞏ Excepted quantities (EQ)ꞏ Transport categoryꞏ Tunnel restriction codeꞏ IMDGꞏ Limited quantities (LQ)ꞏ Excepted quantities (EQ)ꞏ UN "Model Regulation":

5L
Code: E1
Maximum net quantity per inner packaging: 30 ml
Maximum net quantity per outer packaging: 1000 ml
3(-)
5L
Code: E1
Maximum net quantity per inner packaging: 30 ml
Maximum net quantity per outer packaging: 1000 ml
UN 3082 ENVIRONMENTALLY HAZARDOUS
SUBSTANCE, LIQUID, N.O.S. (CYANOGEN BROMIDE), 9,III

SECTION 15: Regulatory information
ꞏ 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixtureꞏ Directive 2012/18/EU
ꞏ Named dangerous substances - ANNEX I None of the ingredients is listed.
ꞏ Seveso category E2 Hazardous to the Aquatic Environment
ꞏ Qualifying quantity (tonnes) for the application of lower-tier requirements 200 t
ꞏ Qualifying quantity (tonnes) for the application of upper-tier requirements 500 t(Contd. on page 8)EU

57.0.21

Page 8/8

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 14.09.2023

Trade name: AlphaLISA Human IFNb Analyte(Contd. of page 7)

ꞏ REGULATION (EC) No 1907/2006 ANNEX XVII Conditions of restriction: 3
ꞏ DIRECTIVE 2011/65/EU on the restriction of the use of certain hazardous substances in electrical andelectronic equipment – Annex II
None of the ingredients is listed.
ꞏ REGULATION (EU) 2019/1148
ꞏ Annex I - RESTRICTED EXPLOSIVES PRECURSORS (Upper limit value for the purpose of licensing under
Article 5(3))
None of the ingredients is listed.
ꞏ Annex II - REPORTABLE EXPLOSIVES PRECURSORSNone of the ingredients is listed.
ꞏ Regulation (EC) No 273/2004 on drug precursors
7647-01-0 hydrochloric acid3

ꞏ Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third
countries in drug precursors
7647-01-0 hydrochloric acid3
ꞏ 15.2 Chemical safety assessment: A Chemical Safety Assessment has not been carried out.

SECTION 16: Other information
The information provided in this safety data sheet is based on our current knowledge,
and is believed to be correct at the date of publication. However, no representation is madeconcerning its accuracy and completeness. It is intended as guidance only, and is not to be regarded as awarranty or specification of quality. All materials may present unknown hazards and should be used withcaution. Although certain hazards are described, we cannot guarantee that these are the only hazards that exist.
Revvity, Inc. cannot be held liable for any damage resulting from handling or contact with the product.
ꞏ Abbreviations and acronyms:
ADR: Accord relatif au transport international des marchandises dangereuses par route (European Agreement Concerning the International
Carriage of Dangerous Goods by Road)
IMDG: International Maritime Code for Dangerous Goods
IATA: International Air Transport Association
GHS: Globally Harmonised System of Classification and Labelling of Chemicals
EINECS: European Inventory of Existing Commercial Chemical Substances
ELINCS: European List of Notified Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
PBT: Persistent, Bioaccumulative and Toxic
vPvB: very Persistent and very Bioaccumulative
Acute Tox. 3: Acute toxicity – Category 3
Acute Tox. 2: Acute toxicity – Category 2
Skin Corr. 1C: Skin corrosion/irritation – Category 1C
Skin Irrit. 2: Skin corrosion/irritation – Category 2
Eye Dam. 1: Serious eye damage/eye irritation – Category 1
Eye Irrit. 2: Serious eye damage/eye irritation – Category 2
Skin Sens. 1: Skin sensitisation – Category 1
Skin Sens. 1A: Skin sensitisation – Category 1AAquatic Acute 1: Hazardous to the aquatic environment - acute aquatic hazard – Category 1
Aquatic Chronic 1: Hazardous to the aquatic environment - long-term aquatic hazard – Category 1
Aquatic Chronic 2: Hazardous to the aquatic environment - long-term aquatic hazard – Category 2EU57.0.21

Page 1/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

SECTION 1: Identification of the substance/mixture and of the company/undertaking
ꞏ 1.1 Product identifier
ꞏ Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL
ꞏ Product number: AL000HV
ꞏ 1.2 Relevant identified uses of the substance or mixture and uses advised against
ꞏ Product category PC21 Laboratory chemicals
ꞏ Application of the substance / the mixture Laboratory chemicals
ꞏ 1.3 Details of the supplier of the safety data sheet
ꞏ Manufacturer/Supplier:Revvity, Inc
549 Albany Street
Boston, MA 02118
ꞏ Further information obtainable from:US Technical Support
800-762-4000
ꞏ 1.4 Emergency telephone number:
If inside USA, call CHEMTREC at 1-800-424-9300
If outside USA, call CHEMTREC at 1-703-527-3887

SECTION 2: Hazards identification
ꞏ 2.1 Classification of the substance or mixture
ꞏ 2.1.1 Classification according to Regulation (EC) No 1272/2008
Acute Tox. 3
H331 Toxic if inhaled.
Skin Irrit. 2
H315 Causes skin irritation.
Eye Irrit. 2
H319 Causes serious eye irritation.
Skin Sens. 1
H317 May cause an allergic skin reaction.
Aquatic Acute 1
H400 Very toxic to aquatic life.
Aquatic Chronic 1 H410 Very toxic to aquatic life with long lasting effects.
ꞏ 2.1.3 Additional information: For the wording of the relevant risk phrases refer to section 16.
ꞏ 2.2 Label elements
ꞏ Labelling according to Regulation (EC) No 1272/2008
The product is classified and labelled according to the CLP regulation.
ꞏ Hazard pictograms

GHS06

GHS09

ꞏ Signal word Dangerꞏ Hazard-determining components of labelling:
5-chloro-2-methyl-2H-isothiazol-3-one
ꞏ Hazard statements
H331 Toxic if inhaled.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H317 May cause an allergic skin reaction.
H410 Very toxic to aquatic life with long lasting effects.
ꞏ Precautionary statements
P261
Avoid breathing dust/fume/gas/mist/vapours/spray.
(Contd. on page 2)EU

57.0.21

Page 2/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL(Contd. of page 1)

P280
Wear protective gloves / eye protection / face protection.
P304+P340
IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if
present and easy to do. Continue rinsing.
P403+P233
Store in a well-ventilated place. Keep container tightly closed.
P501
Dispose of contents/container in accordance with local/regional/national/international
regulations.
ꞏ 2.3 Other hazards
ꞏ Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.
ꞏ Determination of endocrine-disrupting properties
9002-93-1 Polyethylene glycol octylphenol ether
List ISECTION 3: Composition/information on ingredientsꞏ 3.2 Mixtures
ꞏ Description: Mixture of substances listed below with nonhazardous additions.
ꞏ Dangerous components:
CAS: 9002-93-1
Polyethylene glycol octylphenol ether
Eye Irrit. 2, H319; Aquatic Chronic 3, H412
CAS: 26172-55-45-chloro-2-methyl-2H-isothiazol-3-one
EINECS: 247-500-7
Acute Tox. 3, H301; Acute Tox. 2, H310; Acute Tox. 2, H330;
Skin Corr.
1C, H314; Eye Dam. 1, H318;
Aquatic Acute 1, H400 (M=100); Aquatic
Chronic 1, H410 (M=100);
Skin Sens. 1A, H317
Specific concentration limits: Skin Corr. 1C; H314: C ≥ 0.6 %Skin Irrit. 2; H315: 0.06 % ≤ C < 0.6 %Eye Dam. 1; H318: C ≥ 0.6 %Eye Irrit. 2; H319: 0.06 % ≤ C < 0.6 %Skin Sens. 1A; H317: C ≥ 0.0015 %2.5-10%<1%

ꞏ SVHC
9002-93-1 Polyethylene glycol octylphenol ether
ꞏ Additional information: For the wording of the relevant risk phrases refer to section 16.

SECTION 4: First aid measuresꞏ 4.1 Description of first aid measuresꞏ General information:
Immediately remove any clothing soiled by the product.
Remove breathing equipment only after contaminated clothing have been completely removed.
In case of irregular breathing or respiratory arrest provide artificial respiration.
ꞏ After inhalation:
Supply fresh air or oxygen; call for doctor.
In case of unconsciousness place patient stably in side position for transportation.
ꞏ After eye contact:
Rinse opened eye for several minutes under running water. If symptoms persist, consult a doctor.
ꞏ After swallowing: If symptoms persist consult doctor.
ꞏ 4.2 Most important symptoms and effects, both acute and delayed No further relevant information available.
(Contd. on page 3)EU

57.0.21

Page 3/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL(Contd. of page 2)

ꞏ 4.3 Indication of any immediate medical attention and special treatment needed
No further relevant information available.

SECTION 5: Firefighting measuresꞏ 5.1 Extinguishing media
ꞏ Suitable extinguishing agents: Use fire extinguishing methods suitable to surrounding conditions.
ꞏ 5.2 Special hazards arising from the substance or mixture No further relevant information available.
ꞏ 5.3 Advice for firefighters
ꞏ Protective equipment: Wear self-contained respiratory protective device.

SECTION 6: Accidental release measuresꞏ 6.1 Personal precautions, protective equipment and emergency procedures Not required.
ꞏ 6.2 Environmental precautions:
Do not allow product to reach sewage system or any water course.
Inform respective authorities in case of seepage into water course or sewage system.
Do not allow to enter sewers/ surface or ground water.
ꞏ 6.3 Methods and material for containment and cleaning up:
Absorb with liquid-binding material (sand, diatomite, acid binders, universal binders, sawdust).
Dispose contaminated material as waste according to section 13.
Ensure adequate ventilation.
ꞏ 6.4 Reference to other sections
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.

SECTION 7: Handling and storage
ꞏ 7.1 Precautions for safe handling
Ensure good ventilation/exhaustion at the workplace.
Open and handle receptacle with care.
Prevent formation of aerosols.
ꞏ Information about fire - and explosion protection: Keep respiratory protective device available.
ꞏ 7.2 Conditions for safe storage, including any incompatibilities
ꞏ Storage:ꞏ Requirements to be met by storerooms and containers: No special requirements.
ꞏ Information about storage in one common storage facility: Not required.
ꞏ Further information about storage conditions: Keep container tightly sealed.
ꞏ Storage class: 6.1 Dꞏ 7.3 Specific end use(s) No further relevant information available.

SECTION 8: Exposure controls/personal protection
ꞏ 8.1 Control parameters
ꞏ Ingredients with limit values that require monitoring at the workplace:
The product does not contain any relevant quantities of materials with critical values that have to be monitored at
the workplace.
(Contd. on page 4)EU

57.0.21

Page 4/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL(Contd. of page 3)

ꞏ 8.2 Exposure controlsꞏ Appropriate engineering controls No further data; see section 7.
ꞏ Individual protection measures, such as personal protective equipment
ꞏ General protective and hygienic measures:
Keep away from foodstuffs, beverages and feed.
Immediately remove all soiled and contaminated clothing
Wash hands before breaks and at the end of work.
Store protective clothing separately.
Avoid contact with the eyes and skin.
ꞏ Respiratory protection:
In case of brief exposure or low pollution use respiratory filter device. In case of intensive or longer exposure use
self-contained respiratory protective device.
Suitable respiratory protective device recommended.
ꞏ Hand protection
Protective gloves
The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation
ꞏ Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality andvaries from manufacturer to manufacturer. As the product is a preparation of several substances, the resistanceof the glove material can not be calculated in advance and has therefore to be checked prior to the application.
ꞏ Penetration time of glove material
The exact break through time has to be found out by the manufacturer of the protective gloves and has to beobserved.
ꞏ Eye/face protection
Tightly sealed goggles

SECTION 9: Physical and chemical properties
ꞏ 9.1 Information on basic physical and chemical properties
ꞏ General Information
Fluidꞏ Physical state
According to product specification
ꞏ Colour:Characteristic
ꞏ Odour:Not determined.
ꞏ Odour threshold:
Undetermined.
ꞏ Melting point/freezing point:ꞏ Boiling point or initial boiling point and boiling range 100 °C
Not applicable.
ꞏ Flammability
ꞏ Lower and upper explosion limit
Not determined.
ꞏ Lower:Not determined.
ꞏ Upper:
Not applicable.
ꞏ Flash point:
Not determined.
ꞏ Decomposition temperature:
Not determined.
ꞏ pH(Contd. on page 5)EU

57.0.21

Page 5/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL(Contd. of page 4)

ꞏ Viscosity:
ꞏ Kinematic viscosity
ꞏ Dynamic:
ꞏ Solubilityꞏ water:ꞏ Partition coefficient n-octanol/water (log value)ꞏ Vapour pressure at 20 °C:
ꞏ Density and/or relative density
ꞏ Density:ꞏ Relative density
ꞏ Vapour density

Not determined.
Not determined.
Not miscible or difficult to mix.
Not determined.
23 hPaNot determined.
Not determined.
Not determined.

ꞏ 9.2 Other information
ꞏ Appearance:
Fluidꞏ Form:ꞏ Important information on protection of health andenvironment, and on safety.
Product is not selfigniting.
ꞏ Ignition temperature:
Product does not present an explosion hazard.
ꞏ Explosive properties:
ꞏ Solvent content:85.4 %
ꞏ Water:
0.4 %ꞏ Solids content:
ꞏ Change in condition
Not determined.
ꞏ Evaporation rateꞏ Information with regard to physical hazard classes
Voidꞏ Explosives
Voidꞏ Flammable gases
Voidꞏ Aerosols
Voidꞏ Oxidising gases
Voidꞏ Gases under pressure
Voidꞏ Flammable liquids
Voidꞏ Flammable solids
Voidꞏ Self-reactive substances and mixtures
Voidꞏ Pyrophoric liquids
Voidꞏ Pyrophoric solids
Voidꞏ Self-heating substances and mixtures
ꞏ Substances and mixtures, which emit flammable gases
Voidin contact with waterVoidꞏ Oxidising liquids
Voidꞏ Oxidising solids
Voidꞏ Organic peroxides
Voidꞏ Corrosive to metals
Voidꞏ Desensitised explosives

SECTION 10: Stability and reactivityꞏ 10.1 Reactivity No further relevant information available.
ꞏ 10.2 Chemical stability
ꞏ Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications.
ꞏ 10.3 Possibility of hazardous reactions No dangerous reactions known.
ꞏ 10.4 Conditions to avoid No further relevant information available.
ꞏ 10.5 Incompatible materials: No further relevant information available.
(Contd. on page 6)EU

57.0.21

Page 6/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL(Contd. of page 5)

ꞏ 10.6 Hazardous decomposition products: No dangerous decomposition products known.

SECTION 11: Toxicological information
ꞏ 11.1 Information on hazard classes as defined in Regulation (EC) No 1272/2008
ꞏ Acute toxicity Toxic if inhaled.
ꞏ Skin corrosion/irritation Causes skin irritation.
ꞏ Serious eye damage/irritation Causes serious eye irritation.
ꞏ Respiratory or skin sensitisation May cause an allergic skin reaction.
ꞏ Germ cell mutagenicity Based on available data, the classification criteria are not met.
ꞏ Carcinogenicity Based on available data, the classification criteria are not met.
ꞏ Reproductive toxicity Based on available data, the classification criteria are not met.
ꞏ STOT-single exposure Based on available data, the classification criteria are not met.
ꞏ STOT-repeated exposure Based on available data, the classification criteria are not met.
ꞏ Aspiration hazard Based on available data, the classification criteria are not met.
ꞏ 11.2 Information on other hazards
ꞏ Endocrine disrupting properties
9002-93-1 Polyethylene glycol octylphenol ether

List ISECTION 12: Ecological information
ꞏ 12.1 Toxicity
ꞏ Aquatic toxicity: No further relevant information available.
ꞏ 12.2 Persistence and degradability No further relevant information available.
ꞏ 12.3 Bioaccumulative potential No further relevant information available.
ꞏ 12.4 Mobility in soil No further relevant information available.
ꞏ 12.5 Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.
ꞏ 12.6 Endocrine disrupting properties For information on endocrine disrupting properties see section 11.
ꞏ 12.7 Other adverse effects
ꞏ Remark: Very toxic for fish

SECTION 13: Disposal considerations
ꞏ 13.1 Waste treatment methods
ꞏ Recommendation
Hand over to hazardous waste disposers.
Must be specially treated adhering to official regulations.
Must not be disposed together with household garbage. Do not allow product to reach sewage system.
ꞏ Uncleaned packaging:ꞏ Recommendation: Disposal must be made according to official regulations.

SECTION 14: Transport information
ꞏ 14.1 UN number or ID number
ꞏ ADR, IMDG, IATA

UN2810(Contd. on page 7)EU

57.0.21

Page 7/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL(Contd. of page 6)

ꞏ 14.2 UN proper shipping name
ꞏ ADR
ꞏ IMDG
ꞏ IATA

2810 TOXIC LIQUID, ORGANIC, N.O.S. (CYANOGENBROMIDE), ENVIRONMENTALLY HAZARDOUS
TOXIC LIQUID, ORGANIC, N.O.S. (CYANOGENBROMIDE), MARINE POLLUTANTTOXIC LIQUID, ORGANIC, N.O.S. (CYANOGENBROMIDE)ꞏ 14.3 Transport hazard class(es)ꞏ ADR, IMDG

ꞏ Class
ꞏ Label

6.1 Toxic substances.
6.1

ꞏ IATAꞏ Class
ꞏ Label

6.1 Toxic substances.
6.1

ꞏ 14.4 Packing group
ꞏ ADR, IMDG, IATA

IIIꞏ Marine pollutant:ꞏ Special marking (ADR):

Product contains environmentally hazardous substances: 5chloro-2-methyl-2H-isothiazol-3-one
Symbol (fish and tree)
Symbol (fish and tree)

ꞏ 14.6 Special precautions for user
ꞏ Hazard identification number (Kemler code):ꞏ EMS Number:ꞏ Segregation groupsꞏ Stowage Category
ꞏ Stowage CodeWarning: Toxic substances.
60
F-A,S-A(SGG6) Cyanides
A
SW2 Clear of living quarters.

ꞏ 14.5 Environmental hazards:

ꞏ 14.7 Maritime transport in bulk according to IMO
Not applicable.
instruments
ꞏ Transport/Additional information:
ꞏ ADR
ꞏ Limited quantities (LQ)ꞏ Excepted quantities (EQ)ꞏ Transport categoryꞏ Tunnel restriction code

5L
Code: E1
Maximum net quantity per inner packaging: 30 ml
Maximum net quantity per outer packaging: 1000 ml
2
E(Contd. on page 8)EU

57.0.21

Page 8/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL(Contd. of page 7)

ꞏ IMDGꞏ Limited quantities (LQ)ꞏ Excepted quantities (EQ)ꞏ UN "Model Regulation":

5L
Code: E1
Maximum net quantity per inner packaging: 30 ml
Maximum net quantity per outer packaging: 1000 ml
UN 2810 TOXIC LIQUID, ORGANIC, N.O.S. (CYANOGENBROMIDE), 6.1, III, ENVIRONMENTALLY HAZARDOUS

SECTION 15: Regulatory information
ꞏ 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixtureꞏ Directive 2012/18/EU
ꞏ Named dangerous substances - ANNEX I None of the ingredients is listed.
ꞏ Seveso category
H2 ACUTE TOXIC
E1 Hazardous to the Aquatic Environment
ꞏ Qualifying quantity (tonnes) for the application of lower-tier requirements 50 t
ꞏ Qualifying quantity (tonnes) for the application of upper-tier requirements 200 t
ꞏ LIST OF SUBSTANCES SUBJECT TO AUTHORISATION (ANNEX XIV)
9002-93-1 Polyethylene glycol octylphenol ether
Sunset date: 2021-01-04
ꞏ REGULATION (EC) No 1907/2006 ANNEX XVII Conditions of restriction: 3
ꞏ DIRECTIVE 2011/65/EU on the restriction of the use of certain hazardous substances in electrical andelectronic equipment – Annex II
None of the ingredients is listed.
ꞏ REGULATION (EU) 2019/1148
ꞏ Annex I - RESTRICTED EXPLOSIVES PRECURSORS (Upper limit value for the purpose of licensing under
Article 5(3))
None of the ingredients is listed.
ꞏ Annex II - REPORTABLE EXPLOSIVES PRECURSORSNone of the ingredients is listed.
ꞏ Regulation (EC) No 273/2004 on drug precursors
None of the ingredients is listed.
ꞏ Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third
countries in drug precursors
None of the ingredients is listed.
ꞏ National regulations:ꞏ Other regulations, limitations and prohibitive regulations
ꞏ Substances of very high concern (SVHC) according to REACH, Article 57
9002-93-1 Polyethylene glycol octylphenol ether
ꞏ 15.2 Chemical safety assessment: A Chemical Safety Assessment has not been carried out.

SECTION 16: Other information
The information provided in this safety data sheet is based on our current knowledge,
and is believed to be correct at the date of publication. However, no representation is madeconcerning its accuracy and completeness. It is intended as guidance only, and is not to be regarded as a(Contd. on page 9)EU

57.0.21

Page 9/9

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: AlphaLISA Immunoassay Buffer 10X, 2 mL(Contd. of page 8)

warranty or specification of quality. All materials may present unknown hazards and should be used withcaution. Although certain hazards are described, we cannot guarantee that these are the only hazards that exist.
Revvity, Inc. cannot be held liable for any damage resulting from handling or contact with the product.
ꞏ Abbreviations and acronyms:
ADR: Accord relatif au transport international des marchandises dangereuses par route (European Agreement Concerning the International
Carriage of Dangerous Goods by Road)
IMDG: International Maritime Code for Dangerous Goods
IATA: International Air Transport Association
GHS: Globally Harmonised System of Classification and Labelling of Chemicals
EINECS: European Inventory of Existing Commercial Chemical Substances
ELINCS: European List of Notified Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
PBT: Persistent, Bioaccumulative and Toxic
SVHC: Substances of Very High Concern
vPvB: very Persistent and very Bioaccumulative
Acute Tox. 3: Acute toxicity – Category 3
Acute Tox. 2: Acute toxicity – Category 2
Skin Corr. 1C: Skin corrosion/irritation – Category 1C
Skin Irrit. 2: Skin corrosion/irritation – Category 2
Eye Dam. 1: Serious eye damage/eye irritation – Category 1
Eye Irrit. 2: Serious eye damage/eye irritation – Category 2
Skin Sens. 1: Skin sensitisation – Category 1
Skin Sens. 1A: Skin sensitisation – Category 1AAquatic Acute 1: Hazardous to the aquatic environment - acute aquatic hazard – Category 1
Aquatic Chronic 1: Hazardous to the aquatic environment - long-term aquatic hazard – Category 1
Aquatic Chronic 3: Hazardous to the aquatic environment - long-term aquatic hazard – Category 3
EU

57.0.21

Page 1/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

SECTION 1: Identification of the substance/mixture and of the company/undertaking
ꞏ 1.1 Product identifier
ꞏ Trade name: Streptavidin Donor Beads
ꞏ Product number: 6760002HV
ꞏ 1.2 Relevant identified uses of the substance or mixture and uses advised against
ꞏ Product category PC21 Laboratory chemicals
ꞏ Application of the substance / the mixture Laboratory chemicals
ꞏ 1.3 Details of the supplier of the safety data sheet
ꞏ Manufacturer/Supplier:Revvity, Inc
549 Albany Street
Boston, MA 02118
ꞏ Further information obtainable from:US Technical Support
800-762-4000
ꞏ 1.4 Emergency telephone number:
If inside USA, call CHEMTREC at 1-800-424-9300
If outside USA, call CHEMTREC at 1-703-527-3887

SECTION 2: Hazards identification
ꞏ 2.1 Classification of the substance or mixture
ꞏ 2.1.1 Classification according to Regulation (EC) No 1272/2008
The product is not classified, according to the CLP regulation.
ꞏ 2.2 Label elements
ꞏ Labelling according to Regulation (EC) No 1272/2008 Void
ꞏ Hazard pictograms Void
ꞏ Signal word Void
ꞏ Hazard statements Void
ꞏ 2.3 Other hazards
ꞏ Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.

SECTION 3: Composition/information on ingredientsꞏ 3.2 Mixtures
ꞏ Description: Mixture of substances listed below with nonhazardous additions.
ꞏ Dangerous components: Void
ꞏ Additional information: For the wording of the relevant risk phrases refer to section 16.

SECTION 4: First aid measuresꞏ 4.1 Description of first aid measuresꞏ General information: No special measures required.
ꞏ After inhalation: Supply fresh air; consult doctor in case of complaints.
ꞏ After skin contact: If skin irritation continues, consult a doctor.
ꞏ After eye contact: Rinse opened eye for several minutes under running water.
ꞏ After swallowing: If symptoms persist consult doctor.
ꞏ 4.2 Most important symptoms and effects, both acute and delayed No further relevant information available.
(Contd. on page 2)EU

57.0.21

Page 2/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: Streptavidin Donor Beads(Contd. of page 1)

ꞏ 4.3 Indication of any immediate medical attention and special treatment needed
No further relevant information available.

SECTION 5: Firefighting measuresꞏ 5.1 Extinguishing media
ꞏ Suitable extinguishing agents: Use fire extinguishing methods suitable to surrounding conditions.
ꞏ 5.2 Special hazards arising from the substance or mixture No further relevant information available.
ꞏ 5.3 Advice for firefighters
ꞏ Protective equipment: Wear self-contained respiratory protective device.

SECTION 6: Accidental release measuresꞏ 6.1 Personal precautions, protective equipment and emergency procedures Not required.
ꞏ 6.2 Environmental precautions: No special measures required.
ꞏ 6.3 Methods and material for containment and cleaning up:
Absorb with liquid-binding material (sand, diatomite, acid binders, universal binders, sawdust).
ꞏ 6.4 Reference to other sections
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.

SECTION 7: Handling and storage
ꞏ 7.1 Precautions for safe handling No special measures required.
ꞏ Information about fire - and explosion protection: No special measures required.
ꞏ 7.2 Conditions for safe storage, including any incompatibilities
ꞏ Storage:ꞏ Requirements to be met by storerooms and containers: No special requirements.
ꞏ Information about storage in one common storage facility: Not required.
ꞏ Further information about storage conditions: None.
ꞏ Storage class: 12
ꞏ 7.3 Specific end use(s) No further relevant information available.

SECTION 8: Exposure controls/personal protection
ꞏ 8.1 Control parameters
ꞏ Ingredients with limit values that require monitoring at the workplace:
The product does not contain any relevant quantities of materials with critical values that have to be monitored at
the workplace.
ꞏ 8.2 Exposure controlsꞏ Appropriate engineering controls No further data; see section 7.
ꞏ Individual protection measures, such as personal protective equipment
ꞏ General protective and hygienic measures:
The usual precautionary measures are to be adhered to when handling chemicals.
ꞏ Respiratory protection: Not required.
ꞏ Hand protection
The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation(Contd. on page 3)EU

57.0.21

Page 3/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: Streptavidin Donor Beads(Contd. of page 2)

ꞏ Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality andvaries from manufacturer to manufacturer. As the product is a preparation of several substances, the resistanceof the glove material can not be calculated in advance and has therefore to be checked prior to the application.
ꞏ Penetration time of glove material
The exact break through time has to be found out by the manufacturer of the protective gloves and has to beobserved.
ꞏ Eye/face protection Goggles recommended during refilling

SECTION 9: Physical and chemical properties
ꞏ 9.1 Information on basic physical and chemical properties
ꞏ General Information
Fluidꞏ Physical state
According to product specification
ꞏ Colour:Characteristic
ꞏ Odour:Not determined.
ꞏ Odour threshold:
0 °C
ꞏ Melting point/freezing point:ꞏ Boiling point or initial boiling point and boiling range 100 °C
Not applicable.
ꞏ Flammability
ꞏ Lower and upper explosion limit
Not determined.
ꞏ Lower:Not determined.
ꞏ Upper:
Not applicable.
ꞏ Flash point:
Not determined.
ꞏ Decomposition temperature:
Not determined.
ꞏ pH
ꞏ Viscosity:
Not determined.
ꞏ Kinematic viscosity
Not determined.
ꞏ Dynamic:
ꞏ Solubility
Not miscible or difficult to mix.
ꞏ water:Not determined.
ꞏ Partition coefficient n-octanol/water (log value)
23 hPaꞏ Vapour pressure at 20 °C:
ꞏ Density and/or relative density
1 g/cm³
ꞏ Density at 20 °C:
Not determined.
ꞏ Relative density
Not determined.
ꞏ Vapour density
ꞏ 9.2 Other information
ꞏ Appearance:
Fluidꞏ Form:ꞏ Important information on protection of health andenvironment, and on safety.
Product is not selfigniting.
ꞏ Ignition temperature:
Product does not present an explosion hazard.
ꞏ Explosive properties:
ꞏ Solvent content:
97.5 %
ꞏ Water:
0.2 %ꞏ Solids content:
18.02 g/molꞏ Molecular weightꞏ Change in condition
Not determined.
ꞏ Evaporation rate
(Contd. on page 4)EU

57.0.21

Page 4/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: Streptavidin Donor Beads(Contd. of page 3)

ꞏ Information with regard to physical hazard classes
Voidꞏ Explosives
Voidꞏ Flammable gases
Voidꞏ Aerosols
Voidꞏ Oxidising gases
Voidꞏ Gases under pressure
Voidꞏ Flammable liquids
Voidꞏ Flammable solids
Voidꞏ Self-reactive substances and mixtures
Voidꞏ Pyrophoric liquids
Voidꞏ Pyrophoric solids
Voidꞏ Self-heating substances and mixtures
ꞏ Substances and mixtures, which emit flammable gases
Voidin contact with waterVoidꞏ Oxidising liquids
Voidꞏ Oxidising solids
Voidꞏ Organic peroxides
Voidꞏ Corrosive to metals
Voidꞏ Desensitised explosives

SECTION 10: Stability and reactivityꞏ 10.1 Reactivity No further relevant information available.
ꞏ 10.2 Chemical stability
ꞏ Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications.
ꞏ 10.3 Possibility of hazardous reactions No dangerous reactions known.
ꞏ 10.4 Conditions to avoid No further relevant information available.
ꞏ 10.5 Incompatible materials: No further relevant information available.
ꞏ 10.6 Hazardous decomposition products: No dangerous decomposition products known.

SECTION 11: Toxicological information
ꞏ 11.1 Information on hazard classes as defined in Regulation (EC) No 1272/2008
ꞏ Acute toxicity Based on available data, the classification criteria are not met.
ꞏ Skin corrosion/irritation Based on available data, the classification criteria are not met.
ꞏ Serious eye damage/irritation Based on available data, the classification criteria are not met.
ꞏ Respiratory or skin sensitisation Based on available data, the classification criteria are not met.
ꞏ Germ cell mutagenicity Based on available data, the classification criteria are not met.
ꞏ Carcinogenicity Based on available data, the classification criteria are not met.
ꞏ Reproductive toxicity Based on available data, the classification criteria are not met.
ꞏ STOT-single exposure Based on available data, the classification criteria are not met.
ꞏ STOT-repeated exposure Based on available data, the classification criteria are not met.
ꞏ Aspiration hazard Based on available data, the classification criteria are not met.
ꞏ 11.2 Information on other hazards
ꞏ Endocrine disrupting properties
None of the ingredients is listed.
EU(Contd. on page 5)

57.0.21

Page 5/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: Streptavidin Donor Beads(Contd. of page 4)

SECTION 12: Ecological information
ꞏ 12.1 Toxicity
ꞏ Aquatic toxicity: No further relevant information available.
ꞏ 12.2 Persistence and degradability No further relevant information available.
ꞏ 12.3 Bioaccumulative potential No further relevant information available.
ꞏ 12.4 Mobility in soil No further relevant information available.
ꞏ 12.5 Results of PBT and vPvB assessment
ꞏ PBT: Not applicable.
ꞏ vPvB: Not applicable.
ꞏ 12.6 Endocrine disrupting properties
The product does not contain substances with endocrine disrupting properties.
ꞏ 12.7 Other adverse effects No further relevant information available.

SECTION 13: Disposal considerations
ꞏ 13.1 Waste treatment methods
ꞏ Recommendation
Smaller quantities can be disposed of with household waste.
Must be specially treated adhering to official regulations.
ꞏ Uncleaned packaging:ꞏ Recommendation: Disposal must be made according to official regulations.

SECTION 14: Transport information
ꞏ 14.1 UN number or ID number
ꞏ ADR, IMDG, IATA

Void

ꞏ 14.2 UN proper shipping nameꞏ ADR, IMDG, IATA

Void

ꞏ 14.3 Transport hazard class(es)ꞏ ADR, ADN, IMDG, IATA
ꞏ ClassVoidꞏ 14.4 Packing group
ꞏ ADR, IMDG, IATA

Void

ꞏ 14.5 Environmental hazards:

Not applicable.

ꞏ 14.6 Special precautions for user

Not applicable.

ꞏ 14.7 Maritime transport in bulk according to IMO
Not applicable.
instruments
ꞏ UN "Model Regulation":

Void
EU

(Contd. on page 6)

57.0.21

Page 6/6

Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 26.02.2024

Version number 1

Revision: 18.05.2023

Trade name: Streptavidin Donor Beads(Contd. of page 5)

SECTION 15: Regulatory information
ꞏ 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixtureꞏ Directive 2012/18/EU
ꞏ Named dangerous substances - ANNEX I None of the ingredients is listed.
ꞏ DIRECTIVE 2011/65/EU on the restriction of the use of certain hazardous substances in electrical andelectronic equipment – Annex II
None of the ingredients is listed.
ꞏ REGULATION (EU) 2019/1148
ꞏ Annex I - RESTRICTED EXPLOSIVES PRECURSORS (Upper limit value for the purpose of licensing under
Article 5(3))
None of the ingredients is listed.
ꞏ Annex II - REPORTABLE EXPLOSIVES PRECURSORSNone of the ingredients is listed.
ꞏ Regulation (EC) No 273/2004 on drug precursors
None of the ingredients is listed.
ꞏ Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third
countries in drug precursors
None of the ingredients is listed.
ꞏ 15.2 Chemical safety assessment: A Chemical Safety Assessment has not been carried out.

SECTION 16: Other information
The information provided in this safety data sheet is based on our current knowledge,
and is believed to be correct at the date of publication. However, no representation is madeconcerning its accuracy and completeness. It is intended as guidance only, and is not to be regarded as awarranty or specification of quality. All materials may present unknown hazards and should be used withcaution. Although certain hazards are described, we cannot guarantee that these are the only hazards that exist.
Revvity, Inc. cannot be held liable for any damage resulting from handling or contact with the product.
ꞏ Abbreviations and acronyms:
ADR: Accord relatif au transport international des marchandises dangereuses par route (European Agreement Concerning the International
Carriage of Dangerous Goods by Road)
IMDG: International Maritime Code for Dangerous Goods
IATA: International Air Transport Association
GHS: Globally Harmonised System of Classification and Labelling of Chemicals
EINECS: European Inventory of Existing Commercial Chemical Substances
ELINCS: European List of Notified Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
PBT: Persistent, Bioaccumulative and Toxic
vPvB: very Persistent and very BioaccumulativeEU